Phase III Breast Cancer Drug Abemaciclib Improves PFS
This CDK inhibitor will ultimately join palbociclib and ribociclib as an option for heavily pretreated MBC ER/PR+ patients who would take... Read More
- Home
- MBC Info
- Treatments
- Living with MBC
- Events
- Awareness
- Support
- About
- Contact
888-500-0370
mbcn@mbcn.org
Day